Clinical trial
3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Drug Eluting Stents in Patients With Non ST-segment Elevation Acute Coronary Syndromes: the RESORB-ACS Randomized Clinical Trial
NCT06409117 is registered in ClinicalTrials.gov with Konstantinos Toutouzas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Drug Eluting Stents in Patients With Non ST-segment Elevation Acute Coronary Syndromes: the RESORB-ACS Randomized Clinical Trial
- Lead sponsor
- Konstantinos Toutouzas
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- October 1, 2024
- Completion date
- December 31, 2027
- Enrollment
- 220 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.